Gut microbiota in hypertension

Current Opinion in Nephrology and Hypertension

Volumn 24, Issue 5, 2015, Pages 403-409

  Jose, Pedro A ^a   Raj, Dominic ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Brain gut microbiome axis; Gastro renal axis; Microbiota; Salt sensitivity

Indexed keywords

ANTIBIOTIC AGENT; DOPAMINE; FREE FATTY ACID RECEPTOR 2; FREE FATTY ACID RECEPTOR 3; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 4; GASTRIN; LEVODOPA; MICRORNA; MYC PROTEIN; NORADRENALIN; OLFACTORY RECEPTOR 78; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; SOLUTE CARRIER FAMILY 4; TOLL LIKE RECEPTOR 5; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; SODIUM CHLORIDE;

ACETYLATION; ACIDAMINOCOCCACEAE; ACTINOBACTERIA; BACTEROIDETES; BLOOD PRESSURE REGULATION; CANCER RISK; DAHL SALT RESISTANT RAT; DAHL SALT SENSITIVE RAT; DNA METHYLATION; ELEVATED BLOOD PRESSURE; ENTEROCHROMAFFIN CELL; EPIGENETICS; FIRMICUTES; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; INTESTINE FLORA; ION TRANSPORT; NONHUMAN; OLFACTORY RECEPTOR; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEOBACTERIA; RENIN RELEASE; REVIEW; SALT INTAKE; SALT SENSITIVITY; SODIUM EXCRETION; SODIUM INTAKE; STOMACH CANCER; ANIMAL; BLOOD PRESSURE; GENETIC EPIGENESIS; GENETICS; KIDNEY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD PRESSURE; EPIGENESIS, GENETIC; GASTROINTESTINAL MICROBIOME; HUMANS; HYPERTENSION; KIDNEY; SODIUM CHLORIDE;

EID: 84942603200     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000149     Document Type: Review

References (132)

1. Pickering TG. Modern definitions and clinical expressions of hypertension. In: Laragh JH, Brenner BM, editors. Hypertension. Pathophysiology, diagnosis, and management, 2nd ed NY: Raven Press; 1995. pp. 17-21.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics: 2014 update: a report from the American Heart Association. Circulation 2014; 129:399-410. doi: 10.1161/01.cir.0000442015.53336.12.
3. Harrap SB Where are all the blood pressure genes Lancet 2003 361 2149-2151.
4. Williams SM, Haines JL, Moore JH. The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings Bioessays 2004; 26:170-179.
5. Williams SM, Cante r JA, Crawford DC, et al. Problems with genome-wide association studies. Science 2007; 316:1840-1842.
6. Padmanabhan S, Caulfield M, Dominiczak AF. Genetic and molecular aspects of h ypertension. Circ Res 2015; 116:937-959. Up-to-date review on the genetics of hypertension and salt sensitivity.
7. Cowley AW Jr., Nadeau JH, Baccarelli A, et al. Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension 2012; 59:899-905.
8. Friso S, Carvajal CA, Fardella CE, Olivieri O. Epigenetics and arterial hypertension: the challenge of emerging evidence. Transl Res 2015; 165: 154-165.
9. Sullivan JM. Salt sensitivity. Definition, conception, methodology, and longterm issues. Hypertension 1991; 17 (1 Suppl):I61-I68.
10. Weinberger MH, Fineberg NS, Fineberg SE, et al. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001; 37:429-432.
11. . Strazzullo P, D'Elia L, Kandala NB, et al. Salt intake, stroke, and cardiovascular disease: meta-Analysis of prospective studies. Br Med J 2009; 339:b4567.
12. He FJ, MacGregor GA. Salt and sugar: their effects on blood pressure. Pflugers Arch 2015; 467:577-586. Review on the interaction of sugar and salt in the pathogenesis of hypertension.
13. Felde r RA, White MJ, Williams SM, et al. Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens 2013; 22:65-76.
14. Suematsu N, Ojaimi C, Recchia FA, et al. Potential mechanisms of lowsodium diet-induced cardiac disease: superoxide-NO in the heart. Circ Res 2010; 106:593-600.
15. Montasser ME, Douglas JA, Roy-Gagnon MH, et al. Determinan ts of blood pressure response to low-salt intake in a healthy adult population. J Clin Hypertens (Greenwich) 2011; 13:795-800.
16. Harsha DW, Sacks FM, Obarzanek E, et al. Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension 2004; 43:393-398.
17. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, et al. Fatal and nonfatal outcomes, incidence of hyper tension, and blood pressure changes in relation to urinary sodium excretion. J Am Med Assoc 2011; 305:1777-1785.
18. O'Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014; 371:612-623.
19. Hall JE, Granger JP, do Carmo JM, et al. Hypertension: physiology and pathophysiology. Compr Physiol 2012; 2:2393-2442.
20. Crowley SD, Gurley SB, Oliverio MI, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-Angiotensin system. J Clin Invest 2005; 11 5:1092-1099.
21. Asico L, Zhang X, Jiang J, et al. Lack of renal dopamine D5 receptors promotes hypertension. J Am Soc Nephrol 2011; 22:82-89.
22. Schlaich MP, Esler MD, Fink GD, et al. Targeting the sympathetic nervous system: critical issues in patient selection, efficacy, and safety of renal denervation. Hypertension 2014; 63:426-432.
23. Kopp UC. Role of renal sensory nerves in physiological and pathophysiological conditions. Am J Physiol Regul Integr Comp Physiol 2015; 308:R79-R95.
24. Coble JP, Grobe JL, Johnson AK, Sigmund CD. Mechani sms of brain renin angiotensin system-induced drinking and blood pressure: importance of the subfornical organ. Am J Physiol Regul Integr Comp Physiol 2015; 308:R238-R249.
25. Nishimoto M, Fujita T. Ren al mechanisms of salt-sensitive hypertension: contribution of two steroid receptor-Associated pathways. Am J Physiol Renal Physiol 2015; 308:F377-F387.
26. Pires NM, Igreja B, Moura E, et al. Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine b-hydroxylase inhibition with etamicastat. Hypertens Res 2015. doi: 10.1038/hr.2015. 50. [Epub ahead of print] Dopamine b-hydroxylase inhibition by etamicastat that does not cross the blood brain barrier decreases blood pressure by preventing the conversion of dopamine to norepinephrine. This results in a decrease in sympathetic activity a nd increase in dopamine availability.
27. Te Riet L,van Esch JH,Roks AJ,et al. Hypertension: renin-Angiotensinaldosterone system alterations Circ Res 2015 116, 960-975.
28. Johnson RJ, Lanaspa MA, Gabriela Sánchez-Lozada L, et al. The discovery of hypertension: evolving views on the role of the kidneys, and current hot topics. Am J Physiol Renal Physiol 2015; 308:F167-F178.
29. Prieto MC, Gonzalez AA, Navar LG. Evolving concepts on regulation and function of renin in distal nephron. Pflugers Arch 2013; 465:121-132.
30. Pollock DM. 2013 Dahl Lecture : American Heart Association council for high blood pressure research clarifying the physiology of endothelin. Hypertension 2014; 63:e110-e117.
31. Rayner B, Ramesar R. The importance of G protein-coupl ed receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment. Int J Mol Sci 2015; 16:5741-5749.
32. Yang J, Villar VA, Jones JE, et al. G protein-coupled receptor kinase 4: role in hypertension. Hypertension 2015; 65:1148-1155.
33. Chugh G, Lokhandwala MF, Asghar M. Altered functioning of both renal dopamine D1 and angiotensin II type 1 receptors causes hypertension in old rats. Hypertension 2012; 59:1029-1036.
34. Zhang MZ, Harris RC. Antihypertensive mechanisms of intra-renal dopamine. Curr Opin Nephrol Hypertens 2015; 24:117-122.
35. Hu MC, Di Sole F, Zhang J, et al. Chronic regulation of the renal Na+/H+ exchanger NHE3 by dopamine: translational and posttranslational mechanisms. Am J Physiol Ren al Physiol 2013; 304:F1169-F1180.
36. Muhammad AB, Lokhandwala MF, Banday AA. Exercise reduces oxidative stress but does not alleviate hyperinsulinemia or renal dopamine D1 receptor dysfunction in obese rats. Am J Physiol Renal Physiol 2011; 300:F98-F104.
37. Fang YJ, Thomas GN, Xu ZL, et al. An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. Int J Cardiol 2005; 102:111-116.
38. Wang X, Li F, Jose PA, Ecelbarger CM. Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and ang iotensin II. Am J Physiol Renal Physiol 2010; 299:F1164-F1170.
39. Michell AR, Debnam ES, Unwin RJ. Regulation of renal function by the gastrointestinal tract: potential role of gut-derived peptides and hormones. Annu Rev Physiol 2008; 70:379-403.
40. Furness JB, Rivera LR, Cho HJ, et al. The gut as a sensory organ. Nat Rev Gastroenterol Hepatol 2013; 10:729-740.
41. Spencer AG, Labonte ED, Rosenbaum DP, et al. Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans. Sci Transl Med 2014; 6:227ra36.
42. Garcia-Perez I, Villasen or A, Wijeyesekera A, et al. Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model. J Proteome Res 2012; 11:4425-4435.
43. Pluznick JL, Protzko RJ, Gevorgyan H, et al. Olfactory recept or responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci USA 2013; 110:4410-4415.
44. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328:228-231.
45. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65.
46. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505:559-563. Fecal deoxycholic acid-A by-product of microbial metabolism that promotes liver cancer-is increased in animal-based diet. Deoxycholic acid causes stress of endoplasmic reticulum and can cause hypertension (J Clin Invest 2012; 122:3960-3964).
47. WuGD, Chen J, Hoffmann C, et al. Linking long-termdietary patterns with gut microbial enterotypes. Science 2011; 334:105-108.
48. Petriz BA, Castro AP, Almeida JA, et al. Exercise induction of gut microbiota modifications in obese, nonobese and hypertensive rats. BMC Genomics 2014; 15:511. Nonobese Wistar-Kyoto and spontaneously hypertensive rats have gut microbiota that are different from obese ra t s. Lactobacilli, greatly increased by exercise, produces lactate that is converted by gut bacteria into butyrate, a beneficial SCFA. The conversion of lactate into butyrate is also enhanced after exercise.
49. Sommer F, Nookaew I , Sommer N, et al. Site-specific programming of the host epithelial transcriptome by the gut microbiota. Genome Biol 2015; 16:62.
50. Min YW,Rhee PL. The role of microbiota on the gut immunology Clin Ther 2015 37 968-975 10.1016/j.clinthera.2015.03.009. [Epub ahead of print]
51. Gregory JC, Buffa JA, Org E, et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem 2015; 290:5647-5660.
52. Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 2014; 25:657-760.
53. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472:57-63.
54. Tuso P, Stoll SR, Li WW. A plant-based diet, atherogenesis, and coronary artery disease prevention. Perm J 2015; 19:62-67.
55. Tang WH, Wang Z, Kennedy DJ, et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 2015; 116:448-455.
56. Hartiala J, Bennett BJ, Tang WH, et al. Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine. Arterioscler Thromb Vasc Biol 2014; 34:130 7-1313.
57. Pluznick J. A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes 2014; 5:202-207.
58. Kimura I, Ozawa K, Inoue D, et al. The gut microbiota suppresses insulinmediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 2013; 4:1829.
59. Kimura I, Inoue D, Maeda T, et al. Short-chain fatty acids a nd ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci USA 2011; 108:8030-8035.
60. Schiffrin EL. Immune mechanisms in hypertension and vascular injury. Clin Sci (Lond) 2014; 126:267-274.
61. Cotillard A, Kennedy SP, Kong LC, et al. Dietary intervention impact on gut microbial gene richness. Nature 2013; 500:585-858.
62. Brantsaeter AL, Myhre R, Haugen M, et al. Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study. Am J Epidemiol 2011; 174:80 7-815.
63. Yang T, Santisteban MM, Rodriguez V, et al. Gut dysbiosis is linked to hypertension. Hypertension 2015; 65:1331-1340.
64. Hashimoto T, Perlot T, Rehman A, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012; 487: 477-481.
65. Nakamura Y, Yamamoto N, Sakai K, et al. Antihypertensive ef fect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J Dairy Sci 1995; 78:1253-1257.
66. Seppo L, Jauhiainen T, Poussa T, et al. A fermented mil k high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 2003; 77:326-330.
67. Ahrén IL, Xu J, Onning G, et al. Antihypertensive activity of blu eberries fermented by Lactobacillus plantarum DSM 15313 and effects on the gut microbiota in healthy rats. Clin Nutr 2015; 34:719-726. doi: 10.1016/j.clnu.2014.08.009. [Epub ahead of print]
68. Menni C, Mangino M, Cecelja M, et al. Metabolomic study of carotid-femoral pulse-wave velocity in women. J Hypertens 2015; 33:791-796.
69. Khalesi S, Sun J, Buys N, et al. Effect of probiotics on blood pressure: a systematic review and meta-Analysis of randomized, controlled trials. Hypertension 2014; 64:897-903. A meta-Analysis of nine trials showed that consuming probiotics decreased SB P by 3.56 mm Hg and DBP by 2.38 mm Hg, similar to that reported with an intake of less than 2 g of sodium/day.
70. Mell B, Jala VR, Mathew AV, et al. Evidence for a link between gut microbiota and hypertension in the Dahl rat model. Physiol Genomics 2015; 47:187-197. doi: 10.1152/physiolgenomics.00136.2014. [Epub ahead of print]
71. Li Z, Chalazonitis A, Huang YY, et al. Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci 2011; 31:8998-9009.
72. Ridaura V, Belkaid Y. Gut microbiota: the link to your second brain. Cell 2015; 161:193-194.
73. O'Mahony SM,Clarke G,Borre YE. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis Behav Brain Res 2015, 277, 32-48.
74. Chen Y, Asico LD, Zheng S, et al. Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis. Hypertension 2013; 62:927-933.
75. Banday AA, Lokhand wala MF. Novel gastro-renal axis and sodium regulation during hypertension. Hypertension 2013; 62:834-835.
76. Crumeyrolle-Arias M, Jaglin M, Bruneau A. Absence of the gut microbiota enhances a nxiety-like behavior and neuroendocrine response to acute stress in rats. Psychoneuroendocrinology 2014; 42:207-217.
77. Lyte M, Bailey MT. Neuroendocrine-bacterial interactions in a neurotoxininduced model of trauma. J Surg Res 1997; 70:195-201.
78. Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141:599-609.
79. Asano Y, Hiramoto T, Nishino R, et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 2012; 303:G1288-G1295.
80. Vieira-Coelho MA, Soares-da-Silva P. Ontogenic aspects of D1 receptor coupling to G proteins and regulation of rat jejunal Na+, K+ ATPase activity and electrolyte transport. Br J Pharmacol 2000; 129:573-581.
81. Feng XY, Li Y, Li LS, et al. Dopamine D1 receptors mediate dopamineinduced duodenal epithelial ion transport in rats. Transl Res 2013; 161:486-494.
82. Fraga S, Luo Y, Jose P, et al. Dopamine D1-like receptor-mediated inhibition of Cl/HCO3-exchanger activity in rat intestinal epithelial IEC-6 cells is regulated by G protein-coupled receptor kinase 6 (GRK 6). Cell Physiol Biochem 2006; 18:347-360.
83. Lucas-Teixeira V, Serrão MP, Soares-Da-Silva P. Effect of salt intake on jejunal dopamine, Na+,K+-ATPase activity and electrolyte transport. Acta Physiol Scand 2000; 168:225-231.
84. Pestana M, Jardim H, Correia F, et al. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension. Nephrol Dial Transplant 2001; 16 (Suppl 1):53-59.
85. Grossman E, Hoffman A, Tamrat M, et al. Endogenous dopa and dopamine responses to dietary salt loading in salt-sensitive rats. J Hypertens 1991; 9:259-263.
86. Jiang X, Wang W, Ning B, et al. Basal and postprandial serum levels of gastrin in normotensive and hypertensive adults. Clin Exp Hypertens 2013; 35:74-78.
87. Melis M, Krenning EP, Be rnard BF, et al. Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences. Nucl Med Biol 2007; 34:633-641.
88. von Sch renck T, Ahrens M, de Weerth A, et al. CCKB/gastrin receptors mediate changes in sodium and potassium absorption in the isolated perfused rat kidney. Kidney Int 2000; 58:995-1003.
89. Liu T, Jose PA. Gastrin induces sodium-hydrogen exchanger 3 phosphorylation and mTOR activation via a phosphoinositide 3-kinase-/protein kinase Cdependent but AKT-independent pathway in renal proximal tubule cells derived from a normotensive male human. Endocrinology 2013; 154:865-875.
90. Pisegna JR, Tarasova NI, Kopp JA, et al. Postprandial changes in renal function are mediated by elevated serum gastrin acting at cholecystokinin type B receptors (CCKBR) in the kidney (abstract). Gastroenterology 1996; 110:1106A.
91. Hehemann JH, Correc G, Barbeyron T, et al. Transfer of carbohydrate-Active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010; 464:908-912.
92. Slack E, Hapfelmeier S, Stecher BV, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009; 325:617-620.
93. Canani RB, Costanzo MD, Leone L, et al. Epigenetic mechanisms elicited by nutrition in early life. Nutr Res Rev 2011; 24:198-205.
94. Fujita T. Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems J Am Soc Nephrol 2014 25, 1148-1155.
95. Yatabe MS, Yatabe J, Yoneda M, et al. Salt sensitivity is asso ciated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr 2010; 92:77-82.
96. Unlap MT, Bates E, Williams C, et al. Na+/Ca2+ exchanger: target for oxidative stress in salt-sensitive hypertension. Hypertension 2003; 42:363-368.
97. Kanbay M, Chen Y, Solak Y, Sanders PW. Mechanisms and consequences of salt sensitivity and dietary salt intake. Curr Opin Nephrol Hypertens 2011; 20:37-43.
98. Franco V, Oparil S. Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr 2006; 25 (3 Suppl):247S-255S.
99. Carey RM, Schoeffel CD, Gildea JJ, et al. Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension 2012; 60:1359-1366.
100. Padmanabhan S, Graham L, Ferreri NR, et al. Uromodulin, an emerging novel pathway for blood pressure regulation and hypertension. Hypertension 2014; 64:918-923.
101. Garza AE, Rariy CM, Sun B, et al. Variants in striatin gene are associated with salt-sensitive blood pressure in mice and humans. Hypertension 2015; 65:211-217.
102. Svetkey LP, McKeown SP, Wilson AF. Heritability of salt sensitivit y in black Americans. Hypertension 1996; 28:854-858.
103. Beeks E, Kessels AG, Kroon AA, et al. Genetic predisposition to saltsensitivity: a systematic review. J Hypertens 2004; 22:1243-1249.
104. Kelly TN, He J. Genomic epidemiology of blood pressure s alt sensitivity. J Hypertens 2012; 30:861-873.
105. Felder RA, Sanada H, Xu J, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 2002; 99:3872-3877.
106. Wang Z, Armando I, Asico LD, et al. Th e elevated blood pressure of human GRK4gamma A142 V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol 2007; 292:H2083-H2092.
107. Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. S c ience 2002; 298:2345-2349.
108. Ehret GB, Caulfield MJ. Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J 2013; 34:951-961.
109. Williams SM, Haines JL. Correcting away the hidden heritability. Ann Hum Genet 2011; 75:348-350 .
110. Hiura Y, Tabara Y, Kokubo Y, et al. A genome-wide association study of hypertension-related phenotypes in a Japanese population. Circ J 2010; 74:2353-2359.
111. Rana BK, Insel PA, Payne SH, et al. Population-based sample reveals genegender interacti o ns in blood pressure in White Americans. Hypertension 2007; 49:96-106.
112. Staessen JA, Kuznetsova T, Zhang H, et al. Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4. Hypertension 2008; 51:1643-1650 .
113. Udali S, Guarini P, Moruzzi S, et al. Cardiovascular epigenetics: from DNA methylation to microRNAs. Mol Aspects Med 2013; 34:883-901.
114. Friso S, Carvajal CA, Fardella CE, et al. Epigenetics and arterial hypertension: the challenge of emerging ev i dence. Transl Res 2015; 165:154-165.
115. Chen LJ, Wei SY, Chiu JJ. Mechanical regulation of epigenetics in vascular biology and pathobiology. J Cell Mol Med 2013; 17:437-448.
116. Schwenk RW, Vogel H, Schürmann A. Genetic and epigenetic control of m etabolic health. Mol Metab 2013; 2:337-347.
117. Tammen SA, Friso S, Choi SW. Epigenetics: the link between nature and nurture. Mol Aspects Med 2013; 34:753-764.
118. Liu Y, Liu P, Yang C, et al. Base-resolution maps of 5-methylcytosine and 5-hydroxymethy lcytosine in Dahl S rats: effect of salt and genomic sequence. Hypertension 2014; 63:827-838.
119. Stilling RM, Dinan TG, Cryan JF. Microbial genes, brain & behaviour: epigenetic regulation of the gut-brain axis. Genes Brain Behav 2014; 13:69-86. This article reviews the importance of gut microbiota in mediating gene-environment interactions.
120. Banday AA, Lau-S, Lokhandwala MF. Oxidative stress causes renal dopamine D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 2008; 51:367-375.
121. Ando K, Matsui H, Fujita M, et al. Protective effect of dietary potassium against cardiovascular damage in salt-sensitive hypertension: possible role of its antioxidant action. Curr Vasc Pharmacol 2010; 8:59-63.
122. Doyle K, Fitzpatrick FA. Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J Bi o l Chem 2010; 285:17417-17424.
123. Williams JS, Chamarthi B, Goodarzi MO, et al. Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension. Am J Hypertens 2012; 25:812-817.
124. Rezaei M, Andrieu T, Neuenschwander S, et al. Reg u lation of 11b-hydroxysteroid dehydrogenase type 2 by microRNA. Hypertension 2014; 64:860-866.
125. Ling S, Nanhwan M, Qian J, et al. Modulation of microRNAs in hypertensioninduced arterial remodeling through the beta1 and beta 3-Adrenoreceptor pathways. J Mol Cell Cardiol 2013; 65:127-136.
126. Guo TS, Zhang J, Mu JJ, et al. High-salt intake suppressed microRNA-133a expression in Dahl SS rat myocardium. Int J Mol Sci 2014; 15:10794-10805.
127. Gildea JJ, Carlson JM, Schoeffel CD, et al. Urinary exosom e miRNome analysis and its applications to salt sensitivity of blood pressure. Clin Biochem 2013; 46:1131-1134.
128. Mu P, Han YC, Betel D, et al. Genetic dissection of the miR-17-92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 2009; 23: 2 806-2811.
129. Li Z, Van Calcar S, Qu C, et al. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci USA 2003; 100:8164-8169.
130. Heideman MR, Wilting RH, Yanover E, et al. Dosage-dependent tumor suppression b y histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function. Blood 2013; 121:2038-2050.
131. Stocks T, Van Hemelrijck M, Manjer J, et al. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndro me and Cancer Project. Hypertension 2012; 59:802-810.
132. D'Elia L, Galletti F, Strazzullo P. Dietary salt intake and risk of gastric cancer. Cancer Treat Res 2014; 159:83-95.